Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-10-30 9:44 pm Purchase | 13D | MIRATI THERAPEUTICS INC MRTX | Boxer Capital LLC | 10,290,847 18.9% | 1,522,564 (+17.36%) | View |
| 2020-09-30 4:33 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Boxer Capital LLC | 2,268,236 5.1% | 2,268,236 (New Position) | View |
| 2020-09-24 4:47 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | Boxer Capital LLC | 4,000,000 5.8% | 4,000,000 (New Position) | View |
| 2020-09-01 4:31 pm Purchase | 13D | ODONATE THERAPEUTICS INC ODT | Boxer Capital LLC | 4,766,886 12.6% | 1,788,124 (+60.03%) | View |
| 2020-08-07 5:15 pm Purchase | 13D | ITEOS THERAPEUTICS INC. ITOS | Boxer Capital LLC | 4,345,016 13% | 4,345,016 (New Position) | View |
| 2020-08-03 4:31 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Boxer Capital LLC | 1,777,194 7.2% | 1,777,194 (New Position) | View |
| 2020-07-29 9:05 pm Purchase | 13D | PANDION THERAPEUTICS INC PAND | Boxer Capital LLC | 2,107,513 7.4% | 2,107,513 (New Position) | View |
| 2020-07-20 4:37 pm Purchase | 13G | THERAPEUTICS ACQUISITION CORP RACA | Boxer Capital LLC | 1,500,000 8.8% | 1,500,000 (New Position) | View |
| 2020-06-29 6:19 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | Boxer Capital LLC | 2,202,812 7.8% | 2,202,812 (New Position) | View |
| 2020-06-05 4:31 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 20,361,875 9.5% | 8,109,160 (+66.18%) | View |
| 2020-05-11 5:16 pm Purchase | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Boxer Capital LLC | 2,763,569 7.6% | 2,763,569 (New Position) | View |
| 2020-03-02 5:27 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Boxer Capital LLC | 12,252,715 9.8% | 12,252,715 (New Position) | View |
| 2020-02-14 4:56 pm Sale | 13G | MEDICINES COMPANY MDCO | Boxer Capital LLC | 967,000 11% | -3,043,742 (-75.89%) | View |
| 2020-02-14 4:47 pm Sale | 13G | ROCKET PHARMACEUTICALS INC RCKT | Boxer Capital LLC | 1,466,051 2.7% | -500,000 (-25.43%) | View |
| 2020-02-14 4:46 pm Purchase | 13D | MIRATI THERAPEUTICS INC MRTX | Boxer Capital LLC | 8,768,283 18.7% | 1,170,000 (+15.40%) | View |
| 2020-02-14 4:46 pm Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Boxer Capital LLC | 975,100 3.6% | -789,549 (-44.74%) | View |
| 2020-02-14 4:35 pm Unchanged | 13G | ATRECA INC BCEL | Boxer Capital LLC | 1,733,583 7.9% | 0 (Unchanged) | View |
| 2020-02-14 4:32 pm Sale | 13G | SOLID BIOSCIENCES INC SLDB | Boxer Capital LLC | 3,201,689 6.6% | -733,071 (-18.63%) | View |
| 2020-02-14 4:28 pm Purchase | 13G | MATINAS BIOPHARMA HLDGS INC CO MTNB | Boxer Capital LLC | 10,188,312 6.3% | 4,545,454 (+80.55%) | View |
| 2020-02-14 4:27 pm Unchanged | 13G | CABALETTA BIO INC CABA | Boxer Capital LLC | 1,566,361 8.9% | 0 (Unchanged) | View |